Newsroom
Sorted by: Latest
-
Deadline Approaching: First Solar, Inc. (FSLR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming August 24, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR) securities between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”).IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FIRST SOLAR, INC. (FSLR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN...
-
Longbridge Financial's Melissa Macerato Named a 2026 HousingWire Woman of Influence
PARAMUS, N.J.--(BUSINESS WIRE)--Longbridge Financial, LLC, a leading national mortgage lender and servicer specializing in home equity solutions for older Americans, today announced that Chief Revenue and Marketing Officer Melissa Macerato has been named a 2026 HousingWire Woman of Influence. Now in its second decade, the annual recognition highlights female leaders making outstanding contributions to the mortgage and real estate industries, with an emphasis on achievements over the past 12 mon...
-
Cotiviti Recognized by Everest Group as the Highest-Designated Leader for Market Impact in the 2026 Pre-payment Integrity Solutions PEAK Matrix® Assessment
SALT LAKE CITY--(BUSINESS WIRE)--Cotiviti has been recognized as the highest Leader for market impact by Everest Group's 2026 Pre-payment Integrity Solutions PEAK Matrix® Assessment....
-
SC Therapeutics lance l'essai REACH2 pour le traitement de toux chronique réfractaire
BOSTON--(BUSINESS WIRE)--SC Therapeutics, société biopharmaceutique en phase clinique pionnière dans le développement de traitements désactivant les canaux ioniques mécanosensibles (CIM) visant à traiter les maladies respiratoires et cardiovasculaires, annonce aujourd'hui le lancement de l'essai REACH2. Cette étude évaluera le principal produit candidat de la société chez des patients atteints de toux chronique réfractaire (TCR), une maladie invalidante pour laquelle il n'existe actuellement au...
-
LABUBU Takes Over NYC, POP MART Celebrates THE MONSTERS With 10th Anniversary Exhibition
NEW YORK--(BUSINESS WIRE)--LABUBU Takes Over NYC, POP MART Celebrates THE MONSTERS With 10th Anniversary Exhibition...
-
California Cannabis Awards Announces 2026 Medalists, Including First-Ever Home Grow Winners
SACRAMENTO, Calif.--(BUSINESS WIRE)--The California Cannabis Awards (CCAs), in partnership with the California State Fair, today announced the medalists in the 2026 competition, honoring dozens of brands across ten categories, including the new Home Grow Competition. The prestigious contest reflects California's growing recognition of cannabis alongside other award-winning state fair programs, including wine and olive oil. Open to all licensed California cannabis growers, manufacturers, and bra...
-
SC Therapeutics startet die REACH2-Studie zur Behandlung von refraktärem chronischem Husten
BOSTON--(BUSINESS WIRE)--SC Therapeutics, ein biopharmazeutisches Unternehmen im klinischen Stadium, das Pionierarbeit bei Therapien leistet, die mechanosensitive Ionenkanäle (MSCs) deaktivieren, um Atemwegs- und Herz-Kreislauf-Erkrankungen zu behandeln, gibt heute den Start der REACH2-Studie bekannt. Die Studie wird den führenden Produktkandidaten des Unternehmens bei Patienten mit refraktärem chronischem Husten (RCC) untersuchen – einer schwerwiegenden Erkrankung, für die es derzeit keine kra...
-
Deadline Alert: Futu Holdings Limited (FUTU) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 25, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ: FUTU) securities between May 24, 2023 and May 27, 2026, inclusive (the “Class Period”).IF YOU SUFFERED A LOSS ON YOUR FUTU INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO...
-
Guitar Center’s Drum-Off Returns to Hollywood to Crown Its Next Champion on August 20 at the Iconic Fonda Theatre
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Guitar Center’s Drum-Off returns August 20 at Hollywood’s Fonda Theatre, where six finalists compete for $25,000 and a career-changing prize....
-
Samenvatting: SC Therapeutics start een REACH2-onderzoek voor refractaire chronische hoest
BOSTON--(BUSINESS WIRE)--SC Therapeutics, een biofarmaceutisch bedrijf in klinische fase dat pionierswerk verricht ten behoeve van therapieën die MSC's (Mechano-Sensitive ion Channels = mechanosensitieve ionkanalen) deactiveren om aandoeningen van de luchtwegen en cardiovasculaire ziekten te behandelen, meldt vandaag de aanvang van een REACH-onderzoek. De studie zal het kandidaathoofdproduct van het bedrijf evalueren bij patiënten met RCC (refractaire chronische hoest) – een verzwakkende aandoe...